Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Dittmer

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Immunology Letters|June 1, 1996
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletionC Stahl-Hennig, U Dittmer, T Nisslein, et al.
Journal of Virology|March 1, 1997
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2B R Gundlach, H Linhart, U Dittmer, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Journal of Immunological Methods|July 29, 2008
Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuationW U Dittmer, P de Kievit, M W J Prins, et al.
Journal of Virology|March 1, 1995
Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfectionH Petry, U Dittmer, C Stahl-Hennig, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
AIDS (London, England)|June 1, 1993
Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virusC Stahl-Hennig, G Voss, U Dittmer, et al.
Virology|February 15, 1996
Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivoW Luke, C Coulibaly, U Dittmer, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Live attenuated SIV vaccines are not effective in a postexposure vaccination modelH Linhart, B R Gundlach, S Sopper, et al.
The Journal of Infection|November 27, 2020
A model to identify individuals with a high probability of a SARS-CoV-2 infectionB Kowall, M Nonnemacher, B Brune, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Immunology Letters|June 1, 1996
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletionC Stahl-Hennig, U Dittmer, T Nisslein, et al.
Journal of Virology|March 1, 1997
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2B R Gundlach, H Linhart, U Dittmer, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Journal of Immunological Methods|July 29, 2008
Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuationW U Dittmer, P de Kievit, M W J Prins, et al.
Journal of Virology|March 1, 1995
Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfectionH Petry, U Dittmer, C Stahl-Hennig, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
AIDS (London, England)|June 1, 1993
Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virusC Stahl-Hennig, G Voss, U Dittmer, et al.
Virology|February 15, 1996
Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivoW Luke, C Coulibaly, U Dittmer, et al.
AIDS Research and Human Retroviruses|May 1, 1997
Live attenuated SIV vaccines are not effective in a postexposure vaccination modelH Linhart, B R Gundlach, S Sopper, et al.
The Journal of Infection|November 27, 2020
A model to identify individuals with a high probability of a SARS-CoV-2 infectionB Kowall, M Nonnemacher, B Brune, et al.
Pageof 7